Author： Rozovski Uri Keating Michael Estrov Zeev
Publisher： Informa Healthcare
ISSN： 1042-8194
Source： Leukemia and Lymphoma, Vol.54, Iss.7, 2013-07, pp. : 1364-1366
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
BRAF mutations in chronic lymphocytic leukemia
By Jebaraj Billy Michael Chelliah
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :
Access to resources
Recommend
Alemtuzumab in chronic lymphocytic leukemia
By James Danelle F Kipps Thomas J
Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. :
By Andritsos Leslie Khoury Hanna
Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. :
Recent Advances in Chronic Lymphocytic Leukemia
By Abbott Brian
Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. :
New Therapies for Chronic Lymphocytic Leukemia
Current Cancer Therapy Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. :